Quince Therapeutics, Inc is a late-stage biotechnology company that focuses on developing and commercializing specialized therapeutics for patients living with rare and debilitating diseases.
Investors 1
| Date | Name | Website |
| 24.08.2026 | Foresite C... | foresiteca... |
Mentions in press and media 1
| Date | Title | Description |
| 19.05.2026 | Quince Therapeutics: $187 Million Private Placement And Orphai Acquisition To Advance Pulmonary Disease Pipeline | Quince Therapeutics announced the acquisition of Orphai Therapeutics along with a private placement financing valued at up to $187 million to expand its pulmonary disease pipeline. The acquisition adds Orphai’s lead program, LAM-001, an inh... |